← 홈

폐암 (NSCLC)

291개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 291개
ADCBiologicCaicun ZhouSN-38, indicated by higher …Phase 2

Gefitinib (Gefitinib)

Non-small-cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 74.9%임상시험 64상태 ACTIVE
ADCBiologicAstraZenecaPhase 3

Pemetrexed/Cisplatin (Pemetrexed/Cisplatin)

Non-Small-Cell Lung Carcinoma NSCLC · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 87.5%임상시험 64상태 RECRUITING
ADCBiologicSuzhou Transcenta Therapeutics …DM1) leading to diabetic ke…Phase 2

Albumin-Paclitaxel (Albumin-Paclitaxel)

Non-small Cell Lung Cancer Metastatic; First-line Treatment · Breast Cancer Early Stage Breast Cancer

#BreastCancerEarlyStageBreastCanc#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 79.5%임상시험 63상태 RECRUITING
AntibodyMerckvedotin after avelumabPhase 1

pembrolizumab (Keytruda, Pembrolizumab (+) Berahyaluronidase alfa)

Advanced or Metastatic Solid Tumors · Metastatic Non-small Cell Lung Cancer

#MetastaticNon-smallCellLungCance#Antibody#Phase1#인기#항체+5
효능 ORR 65.1%임상시험 63상태 ACTIVE
ADCBiologicAstraZenecaPhase 2

Selumetinib (Selumetinib)

Advanced Pancreatic Ductal Adenocarcinoma; Metastatic Pancreatic Ductal Adenocarcinoma · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 19.7%임상시험 63상태 RECRUITING
AntibodyRochegovitecan in patients with …Preclinical

MPDL3280A (Atezolizumab, Atezolizumab (MPDL3280A))

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#Antibody#Preclinical#인기#항체+4
효능 ORR 46.4%임상시험 60상태 ACTIVE
AntibodyBristol Myers SquibbPhase 2

nivolumab (Opdivo, ipilimumab + nivolumab)

Solid Tumor; Non Small Cell Lung Cancer · Solid Tumor

#SolidTumor#Antibody#Phase2#인기#항체+4
효능 ORR 77.8%임상시험 60상태 RECRUITING
ADCBiologicSWOG Cancer Research NetworksPhase 3

Afatinib Dimaleate (Afatinib Dimaleate)

Recurrent Non-Small Cell Lung Carcinoma; Stage IV Non-Small Cell Lung Cancer · FRα

#FR#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 96%임상시험 59상태 RECRUITING
ADCBiologicMerck Sharp & Dohme LLCGovitecan in gynecologic ma…Phase 3

sacituzumab govitecan (Trodelvy, Sacituzumab tirumotecan)

Lung Neoplasm Malignant · Endometrial Cancer

#EndometrialCancer#ADC#Phase3#인기#항체약물접합체+5
임상시험 55상태 RECRUITING
CGTBiologicShenzhen Hornetcorn Bio-technol…Preclinical

CIK cell therapy (CIK cell therapy)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#CGT#Preclinical#인기#세포유전치료+4
임상시험 54상태 ACTIVE
ADCBiologicAstraZenecaPhase 2

Cediranib (Cediranib)

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#ADC#Phase2#인기#항체약물접합체+3
효능 ORR 26%임상시험 54상태 RECRUITING
ADCBiologicPfizerPhase 3

Docetaxel monotherapy (Docetaxel monotherapy)

Non-small Cell Carcinoma; Non-Small Cell Lung Cancer Metastatic · Non-small Cell Carcinoma

#Non-smallCellCarcinoma#ADC#Phase3#인기#항체약물접합체+3
효능 ORR 95%임상시험 54상태 RECRUITING
ADCBiologicPfizerderuxtecan have preventive …Phase 2

lorlatinib (lorlatinib)

Non-Small Cell Lung Cancer · Cancer

#Cancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 75.8%임상시험 52상태 DISCONTINUED
AntibodyJanssenderuxtecan, datopotamab der…Phase 3

Amivantamab (Amivantamab)

Carcinoma, Non-Small-Cell Lung · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#인기#항체+5
효능 ORR 4.3%임상시험 51상태 RECRUITING
ADCBiologicAmgenbiodistributionPhase 2

Sotorasib (Sotorasib)

Colorectal Cancer; Resectable Colorectal Carcinoma · Locally Advanced Lung Non-Small Cell Car

#LocallyAdvancedLungNon-SmallCell#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 0%임상시험 51상태 RECRUITING
ADCBiologicPharmaMarderuxtecan in patients with…Phase 3

Lurbinectedin (Lurbinectedin)

Small-cell Lung Cancer; Relapsed Small Cell Lung Cancer · Small Cell Lung Cancer

#SmallCellLungCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+5
효능 ORR 40.7%임상시험 48상태 RECRUITING
CGTBiologicBiohaven Pharmaceuticals, Inc.Phase 3

Autologous cytokine-induced killer cell (Autologous cytokine-induced killer cell)

Non-small Cell Lung Cancer · Small Cell Lung Cancer

#SmallCellLungCancer#CGT#Phase3#세포유전치료#CAR-T+4
임상시험 46상태 ACTIVE
ADCBiologicPfizerderuxtecan showed encouragi…Phase 1

Dacomitinib (Dacomitinib)

Non-Small Cell Lung Cancer · FRα

#FR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 75.3%임상시험 46상태 DISCONTINUED
ADCBiologicEMD Serono Research & Developme…Phase 3

M7824 (M7824)

Non-small Cell Lung Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 62.5%임상시험 43상태 DISCONTINUED
AntibodyRocheatApproved

bevacizumab [Avastin] (bevacizumab [Avastin])

Non-Squamous Non-Small Cell Lung Cancer · Pancreatic Cancer

#PancreaticCancer#Antibody#Approved#항체#면역항체+5
효능 ORR 83%임상시험 43상태 ACTIVE

2 / 15 페이지

← 이전다음 →